Status:
UNKNOWN
Effects of Osteopathic Manipulative Treatment in People With Neurogenic Bowel Dysfunction
Lead Sponsor:
University of Turin, Italy
Collaborating Sponsors:
SOMA Istituto Osteopatia Milano
A.O.U. Città della Salute e della Scienza
Conditions:
Central Nervous System Injury
Neurogenic Bowel Dysfunction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
People affected central nervous system (CNS) diseases often suffer from neurogenic bowel dysfunction (NBD) that causes a reduction in the quality of life and participation in social life. Although som...
Detailed Description
Aim of the study The present randomised trial aims to evaluate the efficacy of osteopathic manipulative treatment in supporting the management of neurogenic bowel dysfunction in CNS diseases. Study d...
Eligibility Criteria
Inclusion
- neurogenic bowel dysfunction secondary to acquired disease of the central nervous system
- Neurogenic Bowel Dysfunction Score (NBDS) between 6 and 30
Exclusion
- previous dysfunctional conditions or organic diseases affecting the bowel tract that are pre-existing at neurological diagnosis
- patients with an NBDS score lower than 6 (very mild bowel dysfunction) and above 30 (very severe neurogenic bowel dysfunction)
- ostomy condition (ileus and colon)
- psychiatric patients
- presence of cognitive disorders
- female patients with proven, or even doubtful, pregnancy status.
Key Trial Info
Start Date :
October 28 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04127617
Start Date
October 28 2019
End Date
October 1 2022
Last Update
October 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Silvia Mozzone
Vezza d'Alba, CN, Italy, 12040